USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
HEMOSONICS
Address:
400 Preston Avenue
Suite 250
CHARLOTTESVILLE, VA 22903-4585
Phone:
N/A
URL:
EIN:
120448334
DUNS:
193921041
Number of Employees:
6
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,194,254.00 5
SBIR Phase II $3,753,271.00 2
STTR Phase I $69,992.00 1

Award List:

Miniature, Portable, Device to Detect and Monitor Coagulopathy

Award Year / Program / Phase:
2010 / STTR / Phase I
Award Amount:
$69,992.00
Agency / Branch:
DOD / NAVY
Principal Investigator:
Francesco Viola, VP Engineering and Techno
Research Institution:
The University of Virginia
RI Contact:
Michael G. Glasgow
Abstract:
Trauma is a leading cause of both military and civilian mortality, accounting for roughly 10% of all deaths worldwide. Coagulopathy (disturbance of the physiologic balance between bleeding and clotting) is observed in 25% to 36% of trauma patients and significantly increases mortality.… More

Development of a diagnostic instrument to manage hemostasis in chronic liver dise

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$317,884.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The clinical evaluation and management of hemostasis in the 5 million patients affected by chronic liver diseases (CLD) is poorly understood. Data presented at two International Symposia on Coagulation in Liver Disease and summarized in a recent edition of… More

Development of a point of care diagnostic to guide efficient usage of blood produ

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$298,626.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Over 60% of the 600,000 patients undergoing cardio-pulmonary bypass (CPB) procedures in the US each year experience intra- and post-operative bleeding. Treatment options are available, each corresponding to a specific h emostatic defect: (a) fresh frozen plasma… More

Development of a diagnostic instrument to manage hemostasis in chronic liver dise

Award Year / Program / Phase:
2011 / SBIR / Phase II
Award Amount:
$1,512,209.00
Agency:
HHS
Principal Investigator:
Francesco Viola – 434-409-6281
Abstract:
DESCRIPTION (provided by applicant): The clinical evaluation and management of hemostasis in the 5 million patients affected by chronic liver diseases (CLD) is poorly understood. Data presented at two International Symposia on Coagulation in Liver Diseaseand summarized in a recent edition of Clinics… More

Development of a point of care diagnostic to guide efficient usage of blood produ

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$2,241,062.00
Agency:
HHS
Principal Investigator:
Francesco Viola – (434) 202-1032
Abstract:
DESCRIPTION (provided by applicant): The Problem: Over 60% of the 600,000 patients undergoing cardio-pulmonary bypass (CPB) procedures in the US each year experience excessive bleeding, which requires transfusions of blood products. There are four treatment options available, each corresponding to a… More

A Point-of-Care Device for Diagnosis of Platelet Injury in Trauma Patients

Award Year / Program / Phase:
2014 / SBIR / Phase I
Award Amount:
$149,968.00
Agency / Branch:
DOD / DHP
Principal Investigator:
Francesco Viola, Founder and VP Engineering – (434) 202-1032
Abstract:
HemoSonics LLC is developing an easy to use and easy to interpret diagnostic device to rapidly identify diffuse coagulopathies in order to guide proper and evidence-based interventions. The management of diffuse coagulopathies is extremely important in military medicine as these conditions represent… More

Assessment of Hypercoagulability in Cancer Patients Using Sonorheometry

Award Year / Program / Phase:
2014 / SBIR / Phase I
Award Amount:
$202,931.00
Agency:
HHS
Principal Investigator:
Francesco Viola – 434-202-1032
Abstract:
DESCRIPTION (provided by applicant): The Problem: Venous thromboembolism (VTE), which encompasses the diseases of deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common and life-threatening problem amongst cancer patients. In population-basedstudies, cancer has been associated with a… More

Development of a microfluidic device for the assessment of hemostatic function

Award Year / Program / Phase:
2014 / SBIR / Phase I
Award Amount:
$224,845.00
Agency:
HHS
Principal Investigator:
Francesco Viola – 434-202-1032
Abstract:
DESCRIPTION (provided by applicant): The monitoring and management of the hemostatic balance in neonatal and pediatric patients remains challenging. Although several conditions/procedures are known to have great impact in altering hemostatic function in this population, the differences between … More